Regulatory Expansion The 2025 appointments of Roz Sutton as Head of Regulatory and the regulatory leadership promotion indicate a deliberate strengthening of regulatory capabilities across the business. This signals growing demand for strategic regulatory affairs, dossier preparation, and global submissions services to accelerate product development and approval timelines.

Medical Affairs Growth Simultaneous hires in Medical Affairs leadership and Early Development suggest a focus on scientific communications, clinical evidence generation, and medical information services. This creates opportunities to offer outsourced Medical Affairs support, medical communications, publications planning, and real-world evidence programs.

Commercialisation Focus The addition of Head of Commercialisation and Head of Market Access points to a strategy to maximize product value and payer acceptance. This opens doors for pricing and reimbursement modeling, HEOR studies, launch readiness programs, and integrated market access strategy engagements across regions.

European Growth Potential As a UK-based specialist with a mid-market profile and recent leadership expansions, tranScrip is well-positioned to serve European biotechs and mid-sized pharmas seeking flexible lifecycle services across clinical development, regulatory, and market access.

Digital Transformation Readiness The existing tech stack provides a solid digital backbone; there is potential to deepen automation and analytics across regulatory submissions, medical affairs, and commercial programs through PMO optimization, dashboards, and data integration.